Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study.
Jean-Baptiste Bachet , Lucjan Wyrwicz , Timothy Price , Chiara Cremolini
ESMO open 5 ( 3)
2
2020
Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti-EGFR antibodies in colorectal cancer.
Geraldine Perkins , Astrid Lièvre , Carole Ramacci , Tchao Méatchi
International Journal of Cancer 127 ( 6) 1321 -1331
37
2010
GIST with homozygous KIT exon 11 mutations.
Jean-François Emile , Jean-Baptiste Bachet , Séverine Tabone-Eglinger , Philippe Terrier
Laboratory Investigation 88 ( 5) 456 -457
12
2008
Histologie et pathologie moléculaire des tumeurs stromales gastrointestinales (GIST)
Jean-François Emile , Jean-Baptiste Bachet , Séverine Tabone-Eglinger , Sabrina Brahimi
Revue Francophone Des Laboratoires 2008 ( 398) 53 -58
3
2008
Human equilibrative nucleoside transporter 1 testing in pancreatic ductal adenocarcinoma: A comparison between murine and rabbit antibodies
Magali Svrcek , Jérôme Cros , Raphael Maréchal , Jean-Baptiste Bachet
Histopathology 66 ( 3) 457 -462
32
2015
High c-Met expression in stage I–II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis
Cindy Neuzillet , Anne Couvelard , Annemilaï Tijeras-Raballand , Louis de Mestier
Histopathology 67 ( 5) 664 -676
20
2015
NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial).
Antoine Brouquet , Jean-Baptiste Bachet , Florence Huguet , Mehdi Karoui
BMC Cancer 20 ( 1) 1 -9
5
2020
Toxicité cutanée des anti-EGFR (epidermal growth factor receptor) : algorithme thérapeutique du groupe français PROCUR
Claude Bachmeyer , Ziad Reguiaï , Lucie Peuvrel , Jean-Baptiste Bachet
Bulletin Du Cancer 100 ( 5) 417 -426
2013
Qu’apporte la réponse tumorale dans le cancer colorectal ?
Jean-Baptiste Bachet , Xavier Paoletti , Laure Fournier , Philippe Rougier
Bulletin Du Cancer 100 ( 7) 743 -755
2013
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy , Françoise Desseigne , Marc Ychou , Olivier Bouché
The New England Journal of Medicine 364 ( 19) 1817 -1825
6,992
2011
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Jean-Luc Raoul , Laurence Choné , Eric Francois , Pascal Artru
The New England Journal of Medicine 379 ( 25) 2395 -2406
1,712
2018
Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021
Pascal Hammel , Anthony Turpin , Mehdi el Amrani , Jean-Baptiste Bachet
Cancers 12 ( 12) 3866
3
2020
Treatment of pancreatic cancer: what can we really predict today?
Jean-Baptiste Bachet , Raphael Marechal , Jean-Luc Van Laethem
Cancers 3 ( 1) 675 -699
6
2011
PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker
Jérémy Nigri , Meritxell Gironella , Christian Bressy , Elena Vila-Navarro
Cellular and Molecular Life Sciences 74 ( 22) 4231 -4243
8
2017
KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab
Fréderic Bibeau , Marie-Danièle Diebold , Philippe Rougier , Michel Ducreux
Journal of Clinical Oncology 26 ( 3) 374 -379
1,286
2008
KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
Astrid Lièvre , Jean-Baptiste Bachet , Delphine Le Corre , Valérie Boige
Cancer Research 66 ( 8) 3992 -3995
2,677
2006
S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
Jean-Baptiste Bachet , Raphael Maréchal , Pieter Demetter , Franck Bonnetain
European Journal of Cancer 49 ( 12) 2643 -2653
18
2013
Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13.
Violaine Safar , Florence Duffaud , Jean-Yves Blay , Jean-François Emile
European Journal of Cancer 49 ( 11) 2531 -2541
31
2013
Current standards and new innovative approaches for treatment of pancreatic cancer
Thierry Conroy , Jean-Baptiste Bachet , Ahmet Ayav , Florence Huguet
European Journal of Cancer 57 10 -22
160
2016
Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.
Thomas Aparicio , Dany Gargot , Laurent Teillet , Emilie Maillard
European Journal of Cancer 74 98 -108
27
2017